Analysts Anticipate UnitedHealth Group (UNH) to Announce $3.03 Earnings Per Share

Brokerages expect UnitedHealth Group (NYSE:UNH) to announce $3.03 earnings per share for the current quarter, according to Zacks Investment Research. Six analysts have made estimates for UnitedHealth Group’s earnings. The highest EPS estimate is $3.06 and the lowest is $2.99. UnitedHealth Group posted earnings per share of $2.46 in the same quarter last year, which would suggest a positive year-over-year growth rate of 23.2%. The company is expected to announce its next earnings results on Tuesday, July 17th.

According to Zacks, analysts expect that UnitedHealth Group will report full-year earnings of $12.61 per share for the current year, with EPS estimates ranging from $12.56 to $12.70. For the next year, analysts expect that the company will post earnings of $14.26 per share, with EPS estimates ranging from $13.83 to $14.57. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side research analysts that cover UnitedHealth Group.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.91 by $0.13. The firm had revenue of $55.19 billion for the quarter, compared to analysts’ expectations of $54.90 billion. UnitedHealth Group had a net margin of 5.41% and a return on equity of 22.06%. The business’s quarterly revenue was up 13.3% on a year-over-year basis. During the same quarter last year, the company posted $2.37 EPS.

UNH has been the topic of several recent research reports. Argus increased their target price on shares of UnitedHealth Group to $270.00 and gave the company a “buy” rating in a report on Thursday, January 18th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price on the stock in a report on Saturday, January 20th. Barclays initiated coverage on shares of UnitedHealth Group in a report on Thursday, March 8th. They set an “overweight” rating and a $265.00 target price on the stock. Cantor Fitzgerald reaffirmed a “buy” rating and set a $280.00 target price on shares of UnitedHealth Group in a report on Thursday, March 8th. Finally, Credit Suisse Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Friday, March 9th. Two research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $253.70.

In other news, Director Kenneth Irwin Shine sold 202 shares of the firm’s stock in a transaction dated Thursday, April 19th. The shares were sold at an average price of $237.42, for a total value of $47,958.84. Following the completion of the sale, the director now directly owns 28,948 shares of the company’s stock, valued at approximately $6,872,834.16. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction dated Monday, April 23rd. The stock was sold at an average price of $234.20, for a total transaction of $3,513,000.00. Following the completion of the sale, the director now directly owns 1,761,533 shares of the company’s stock, valued at $412,551,028.60. The disclosure for this sale can be found here. In the last three months, insiders sold 72,019 shares of company stock worth $16,550,733. Insiders own 0.87% of the company’s stock.

Large investors have recently bought and sold shares of the company. Aevitas Wealth Management Inc. purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth about $102,000. Exane Derivatives lifted its position in UnitedHealth Group by 15,333.3% during the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock valued at $102,000 after acquiring an additional 460 shares during the period. Bamco Inc. NY purchased a new position in UnitedHealth Group during the 1st quarter valued at about $117,000. Pathstone Family Office LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $129,000. Finally, Trustcore Financial Services LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $133,000. 87.11% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group opened at $242.96 on Tuesday, MarketBeat.com reports. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.71 and a current ratio of 0.71. The firm has a market cap of $230.16 billion, a PE ratio of 24.13, a P/E/G ratio of 1.38 and a beta of 0.75. UnitedHealth Group has a fifty-two week low of $238.61 and a fifty-two week high of $240.48.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Get a free copy of the Zacks research report on UnitedHealth Group (UNH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply